Why is it rising? Why is it falling? Some explanations on the unusual variations which affect shares during the day’s session on European markets. Only when they are reliable and documented: we avoid telling nonsense as much as possible. Variations are taken at the time of writing the article.
Rising
Software one (+8%): The company active in the software licensing industry notes discussions at an advanced stage for a possible merger with the Norwegian IT company Crayon Group.
Assystem (+6%): The engineering and consulting group announced a share buyback plan for an amount of €20 million.
Soitec (+6%): The producer of materials for the semiconductor industry is supported by Bernstein who believes that the company is finally on the road to recovery after several warnings about its results. The broker notes that Soitec pleasantly surprised last month by publishing results in line with expectations.
Munich RE / Swiss RE (+5% / +4%): The reinsurance giants both presented their outlook for results for next year. The first targets a net profit of 6 billion euros and the second of at least 4.4 billion dollars.
Robert (+2%): The specialist in aromatic products will join the SBF 120 and the CAC Mid 60 alongside Medincell and Planisware. Casino, Euroapi and Eutelsat will be released.
Declining
Impact Asset Management (-26%): The asset manager has been informed of the loss of part of the St. James’s Place activities which ends the mandate of Impax. The termination will take effect in February.
Mobilezone (-15%): The Swiss telecommunications group has revised its forecasts downwards. The latest results published did not live up to expectations.
Novo Nordisk (-3%): In weight loss drugs, Eli Lilly’s Mounjaro is more popular than Danish’s Wegovy in the United Kingdom. Patients consider it more effective. Its price is 40% higher than the Wegovy.
Business